Empire Genomics Corp.

BETHESDA, MD · Founded 2021 · Medtech · Acquired

FISH (Fluorescence In Situ Hybridization) probes for genomic analysis and diagnostics

Claim this profile

Follows are private to you and power your alerts

Updated · empiregenomics.com

Sector
Medtech
Headquarters
BETHESDA, MD
Founded
2021
Latest Form D
$500K, Apr 2021
Total capital
$500K
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$500K
3 Form D · last Apr 2021
66 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

2021FEDERAL ↑EQUITY ↓Cumulative $500K1st Form D$500K
2021FEDERAL ↑EQUITY ↓Cumulative $500K1st Form D$500K

Latest events

  • Private capital raisedForm D · SEC · 1st filing$500K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

2 records have no date or no amount, so they aren’t placed on the timeline.

Founders and team

From SEC Form D filings
  • AARON FISHERExecutive OfficerNamed in SEC Form D filings
  • Anthony JohnsonExecutive Officer, Director, PromoterNamed in SEC Form D filings
  • Daniel PenberthyDirectorNamed in SEC Form D filings
  • Edward ChaitDirectorNamed in SEC Form D filings
  • Michael B. SextonDirectorNamed in SEC Form D filings
  • Norma NowakDirectorNamed in SEC Form D filings
Show all 7 people
  • WILLIAM SNIDERExecutive Officer, Director, PromoterNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .